food for breast cancer patients during chemotherapy

Ngày tải lên: 10/08/2014, 10:21

Ngày tải lên: 09/08/2014, 04:21

Ngày tải lên: 09/08/2014, 09:20

Ngày tải lên: 13/08/2014, 13:20

... individual risks for breast cancer 60-85% and may be identified in 5-10% of all breast cancer cases. 28 Personal history of noninvasive breast cancer or previous abnormal breast biopsy containing ... participants for women age 40-49 years that reported relative risk (RR) reduction in breast cancer mortality. We conducted similar updates for other age groups for context. We used breast cancer ... risk for breast cancer mortality of 0.83 (95% confidence interval [CI], 0.66-1.04) for women randomly assigned to screening, and a number needed to invite for screening to prevent one breast cancer...

Ngày tải lên: 14/02/2014, 21:20

... background for our information in this leaflet below. SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY What are the benefits and harms of attending a screening programme for breast cancer? ... treatment for breast cancer in Norway: comparative analysis of cancer registry data. BMJ 2011;343:d4692. 20. NHS cancer screening programmes. BASO Breast Audit 1999/2000. www.cancerscreening.nhs.uk/breastscreen/publications.html ... disease and cancer. It therefore no longer seems reasonable to attend for breast cancer screening. In fact, by avoiding going to screening, a woman will lower her risk of getting a breast cancer...

Ngày tải lên: 15/02/2014, 05:20

... subtypes in clinical breast cancer. Int J Cancer 2000, 89:209-212. 19. Elston W, Ellis IO: Pathological prognostic factors in breast cancer. The value of histologic grade in breast cancer: expe- rience ... purposes) PAR1 expression in breast cancer patientsFigure 1 PAR1 expression in breast cancer patients. Western blots showing PAR and EGFR expression profiles of tumor biopsy samples from patients with infiltrating ... prognostic factor for invasive breast cancer. Indeed, we found that the clin- ical status or stage of breast cancer in our patients was cor- related with PAR1 overexpression: patients overexpressing PAR1...

Ngày tải lên: 18/06/2014, 15:20

... examined in breast cancer patients after treat- ment. Therefore, we use data from a randomized clinical trial investigating several follow-up strategies for cura- tively treated breast cancer patients ... good prognosis, breast cancer is the most prevalent cancer in the world today [1]. After cura- tive treatment for breast cancer, women attend frequent follow-up visits to be examined for possible ... group program after curative treatment for breast cancer (MaCare trial, ISRCTN 74071417) [10]. Patients in the trial were all female, treated for breast cancer with curative intent, and had no concomitant...

Ngày tải lên: 18/06/2014, 19:20

... nanocapsule form. This observation was consistent with a previous report [48] related to a nanoparticulate form of another anticancer drug (doxorubicin) tested on a different breast cancer cell ... characterized for particle size, zeta potential, EE%, drug release kinetics, morphology, crystallinity, and cytotoxicity on the SUM 225 breast cancer cell line by dynamic light scattering, high performance ... acceptance. Fully formatted PDF and full text (HTML) versions will be made available soon. Encapsulation of docetaxel in oily core polyester nanocapsule intended for breast cancer therapy Nanoscale...

Ngày tải lên: 18/06/2014, 22:20

... the for- mer, the most used in Europe for breast cancer are the European Organization for Research and Treatment of Cancer Core Cancer Quality Life Questionnaire (EORTC QLQ-C30) and its breast- cancer- speci ... health-related quality of life for women with breast cancer. Breast Cancer Res Treat 2005, 93:217-226. 57. Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA: Breast cancer in older women: ... European Organization for Research and Treatment of Cancer; EORTC QLQ-BR23: European Organization for Research and Treatment of Cancer Quality Life Questionnaire Breast Cancer Specific Module;...

Ngày tải lên: 20/06/2014, 15:20

... in human breast cancer cells and therefore have considerable potential for treatment of breast cancer. Keywords Nanoparticles Á MDR Á Pluronic F68 Á Poly (e-caprolactone) Á Docetaxel Á Breast cancer Introduction Cancer ... multidrug resistance in human breast cancer cells and therefore have considerable potential for treatment of breast cancer. Acknowledgments The authors are grateful for financial support from the ... 54.37% for Taxotere Ò to 49.16% (i.e. a 11.42% increase in cytotoxicity, p [ 0.05) for PCL NP formulation and 36.63% (i.e. a 38.88% increase in cyto- toxicity, p \0.05) for PCL/Pluronic F68 NP formulation. Similarly,...

Ngày tải lên: 22/06/2014, 00:20

... treatment is therefore not as effective as it should be. Mortality due to breast cancer is decreasing in most western countries, because of mass screening, frequent use of post-operative chemotherapy ... understood breast cancer heterogeneity better. Two recent papers in Genome Biology from the laboratories of Carlos Caldas [1] and Eric Miska [2] use molecular methods to classify breast cancers ... hheetteerrooggeenneeiittyy Because breast cancer heterogeneity arises from many different factors, several directions of research must be pursued simultaneously if we are to understand and cope with the different forms of breast...

Ngày tải lên: 06/08/2014, 18:21

... does it relate to breast cancer in African-American women? Cancer, 2005, 103(8): 1540-1550. 15. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative ... refined foods and chemical food additives, and decreased intake of fresh fruits and vegetables. Single cases are not generally accepted for genetic testing for hereditary breast cancer genes ... BRCA1 mutations to breast cancer in a North African population, we analysed genomic DNA from breast cancer cases ascertained in Algiers. Both familial cases (at least three breast cancers in the...

Ngày tải lên: 08/08/2014, 17:20

... C-reactive protein level in breast cancer patients Praveen Ravishankaran 1* , R Karunanithi 2 Abstract Background: Breast cancer is a disease that continues to plague females during their entire lifetime. ... IL-6 and CRP in breast carcinoma, and to correlate them with the staging of the disease and the prognosis. Methods: 59 female patients admitted for breast cancer were identified for the study and ... JL: Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987, 56:489-492. 14. Lonn U, Lonn S, Nilsson B, Stenkvist B: Breast cancer: prognostic significance of c-erb-B2 and...

Ngày tải lên: 09/08/2014, 01:24

... CS, Nelson BK: Seroma formation following breast cancer surgery. Breast J 2003, 5:385-8. 10. Woodworth PA, McBoyle MF, Helmer SD, Beamer RL: Seroma formation after breast cancer surgery: incidence ... of seromas following breast cancer surgeries: seromas following breast cancer surgeries. Breast J 2007, 13:588-92. 21. Burak WE Jr, Goodman PS, Young DC, Farrar WB: Seroma formation following ... Adjuvant Breast and Bowel Project: Technical outcomes of sentinel-lymph-node resection and conventional axillary- lymph-node dissection in patients with clinical node-negative patients with breast cancer: ...

Ngày tải lên: 09/08/2014, 02:20

Ngày tải lên: 09/08/2014, 02:21